Arts & CulturePress Release

8 aspiring playwrights chosen for Virgin Labfest 2024 Fellowship Program

Spikes Asia 2025 Spikes Asia 2025 is now open. Download your entry kit!
Sponsor Digicon

MANILA, PHILIPPINES – After its intensive deliberation, the Virgin Labfest (VLF) Writing Fellowship Program announces the eight fellows who will be joining the two-week training workshop slated on June 18 to 30, 2024.

The budding playwrights are:
1. Andrei Michaela Corre
2. Lance Romulus Dayrit
3. Jeremi Flores
4. Ivan Jon Gentolizo
5. Chris Joseph Junio
6. Roel Rocky Pepito
7. Athina Melinette Tirones
8. Philomena Yap

Every year, the Virgin Labfest Writing Fellowship Program calls for aspiring playwrights who are brave enough to learn the best from the best. Award-winning playwright Glenn Mas will once again guide the accepted fellows in their dramatic writing journey.

Sponsor
Announcement of Chosen VLF 19 Fellows

For two weeks, the participants will learn the fundamentals of playwriting, as well as the different aspects of theater production. They will have opportunities to interact and converse with the featured playwrights of VLF 19: Pintog, and industry leaders.

Following the CCP’s desire to guide young aspiring playwrights in finding their artistic voices, the VLF Writing Fellowship Program will host lectures, script critiquing, writing sessions, and interactions with renowned playwrights and directors.

The fellowship program will culminate with Fellowship Showcase, to be directed by CCP artistic director Dennis N. Marasigan, on June 30, 5pm at the Bulwagang Roberto Chabet, 3/F Tanghalang Ignacio Gimenez. The showcase features stage readings of the writing fellows’ final outputs.

For the full festival schedule and ticket prices of Virgin Labfest 19: Pintog, you may visit the official social media accounts of CCP, Tanghalang Pilipino, and Writers’ Bloc on Facebook, X, Instagram, and TikTok. Tickets are available at the CCP Box Office and TicketWorld.

(END)

Partner with adobo Magazine

Related Articles

Leave a Reply

Back to top button